Long Alison S
SEC CIK 1891712 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | Dir | 127.2K | — | — | 3 | 2024-05-29 | 2026-06-01 |
Most active insiders at TSHA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Nagendran Sukumar | Pres, Head of R, D, Dir | — | $5.33M |
| 2 | Nolan Sean P. | CEO, Dir | — | $840.2K |
| 3 | Alam Kamran | CFO | — | $492.5K |
| 4 | Long Alison S | Dir | — | — |
| 5 | Sepp-Lorenzino Laura | Dir | — | — |
| 6 | Stalfort John A III | Dir | — | — |
| 7 | Donenberg Phillip B. | Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-02 16:30 | 2026-06-01 | TSHA | Taysha Gene Therapies, Inc. | Long Alison S | Dir | A - Grant | $0.00 | +21.3K | 127.2K | +20% | $0 |
| D | 2025-06-04 | 2025-06-02 | TSHA | Taysha Gene Therapies, Inc. | Long Alison S | Dir | A - Grant | $0.00 | +56.6K | 105.8K | +115% | $0 |
| D | 2024-05-31 | 2024-05-29 | TSHA | Taysha Gene Therapies, Inc. | Long Alison S | Dir | A - Grant | $0.00 | +49.2K | 49.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations